DaVita Inc. (NYSE:DVA) Given Average Rating of “Hold” by Brokerages

DaVita Inc. (NYSE:DVA) has been given a consensus rating of “Hold” by the five analysts that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating on the company. The average 12 month target price among brokerages that have covered the stock in the last year is $161.80.

A number of equities analysts have weighed in on DVA shares. Truist Financial upped their price objective on shares of DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research report on Monday, October 7th. Barclays raised their price objective on DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st.

DaVita Price Performance

DVA stock opened at $154.30 on Friday. The stock has a 50-day simple moving average of $156.19 and a 200-day simple moving average of $151.27. The firm has a market cap of $12.65 billion, a P/E ratio of 16.65, a price-to-earnings-growth ratio of 0.86 and a beta of 0.90. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. DaVita has a 1 year low of $103.40 and a 1 year high of $169.51.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). The firm had revenue of $3.26 billion for the quarter, compared to analysts’ expectations of $3.25 billion. DaVita had a net margin of 6.53% and a return on equity of 88.18%. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.85 EPS. On average, equities analysts predict that DaVita will post 9.71 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Franklin Resources Inc. lifted its stake in DaVita by 134.6% during the third quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after purchasing an additional 31,502 shares during the last quarter. FMR LLC raised its holdings in shares of DaVita by 659.9% during the third quarter. FMR LLC now owns 177,406 shares of the company’s stock worth $29,082,000 after purchasing an additional 154,061 shares during the period. Atom Investors LP bought a new position in shares of DaVita in the 3rd quarter worth about $4,094,000. Neo Ivy Capital Management acquired a new position in shares of DaVita in the 3rd quarter valued at about $726,000. Finally, Quest Partners LLC bought a new stake in shares of DaVita during the 3rd quarter valued at about $669,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.